Application 761143

Type
BLA
Sponsor
HORIZON THERAPEUTICS IRELAND

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TEPEZZATEPROTUMUMAB-TRBWINJECTABLE;INJECTION500MGYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
75987-130TEPEZZAteprotumumabHorizon Therapeutics USA, Inc.BLACurrent
75987-130TEPEZZAteprotumumabHorizon Therapeutics USA, Inc.BLACurrent
75987-130TEPEZZAteprotumumabHorizon Therapeutics USA, Inc.BLACurrent
75987-130TEPEZZAteprotumumabHorizon Therapeutics USA, Inc.BLACurrent
75987-130TEPEZZAteprotumumabHorizon Therapeutics USA, Inc.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84311SUPPL 2025-11-25
84304SUPPL 2025-11-25
83318SUPPL 2025-09-11
83309SUPPL 2025-09-09
83214SUPPL 2025-08-27
83205SUPPL 2025-08-27
80490SUPPL 2024-12-04
76736SUPPL 2023-12-05
74775SUPPL 2023-07-19
74771SUPPL 2023-07-18
73994SUPPL 2023-04-14
73992SUPPL 2023-04-14
72811SUPPL2022-12-07
72807SUPPL2022-12-07
69140SUPPL2021-10-27
69132SUPPL2021-10-27
62004ORIG2020-03-02
61614ORIG2020-01-22
61611ORIG2020-01-22